ARTICLE | Company News
NewLink Genetics Corp, Merck deal
February 23, 2015 8:00 AM UTC
NewLink said it will receive a $20 million milestone payment from Merck under a 2014 deal granting the pharma exclusive, worldwide rights to develop, commercialize and manufacture Ebola vaccine rVSV-...